Cc5013
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
1267 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Multiple myeloma | D009101 | — | C90.0 | 27 | 65 | 26 | — | 14 | 116 |
| Plasma cell neoplasms | D054219 | — | — | 22 | 53 | 20 | — | 9 | 91 |
| Leukemia | D007938 | — | C95 | 27 | 48 | 3 | — | 3 | 71 |
| Lymphoma | D008223 | — | C85.9 | 26 | 42 | 4 | — | 5 | 61 |
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 16 | 37 | 3 | — | 1 | 50 |
| Myelodysplastic syndromes | D009190 | — | D46 | 16 | 22 | 3 | — | 7 | 43 |
| Lymphoid leukemia | D007945 | — | C91 | 11 | 24 | 3 | — | 1 | 35 |
| Preleukemia | D011289 | — | — | 13 | 17 | 3 | — | 5 | 34 |
| Syndrome | D013577 | — | — | 9 | 19 | 2 | — | 5 | 31 |
| Mantle-cell lymphoma | D020522 | — | C83.1 | 7 | 11 | 2 | — | 3 | 19 |
Show 20 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Myeloid leukemia acute | D015470 | — | C92.0 | 13 | 14 | — | — | 2 | 25 |
| Myeloid leukemia | D007951 | — | C92 | 10 | 13 | — | — | 1 | 20 |
| T-cell lymphoma | D016399 | — | — | 2 | 6 | — | — | — | 7 |
| T-cell lymphoma peripheral | D016411 | — | — | 2 | 4 | — | — | — | 5 |
| Non-small-cell lung carcinoma | D002289 | — | — | 4 | 3 | — | — | — | 5 |
| Myelomonocytic leukemia chronic | D015477 | — | C93.1 | 2 | 4 | — | — | — | 5 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 3 | 4 | — | — | — | 4 |
| Carcinoma | D002277 | — | C80.0 | 3 | 2 | — | — | — | 4 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 4 | 3 | — | — | — | 4 |
| Hodgkin disease | D006689 | — | C81 | 1 | 3 | — | — | — | 4 |
Show 62 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
| B-cell leukemia | D015448 | — | — | 1 | — | — | — | — | 1 |
| Adenoid cystic carcinoma | D003528 | — | — | 1 | — | — | — | — | 1 |
| Neuroendocrine tumors | D018358 | EFO_1001901 | D3A.8 | 1 | — | — | — | — | 1 |
| Hairy cell leukemia | D007943 | — | C91.4 | 1 | — | — | — | — | 1 |
| Disease | D004194 | EFO_0000408 | R69 | 1 | — | — | — | — | 1 |
| Sclerosing cholangitis | D015209 | EFO_0004268 | K83.01 | 1 | — | — | — | — | 1 |
| Immunoglobulin g4-related disease | D000077733 | — | D89.84 | 1 | — | — | — | — | 1 |
| Autoimmune pancreatitis | D000081012 | — | — | 1 | — | — | — | — | 1 |
| Retroperitoneal fibrosis | D012185 | — | K68.2 | 1 | — | — | — | — | 1 |
Show 9 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Systemic lupus erythematosus | D008180 | EFO_0002690 | M32 | — | — | — | — | 1 | 1 |
| Cutaneous lupus erythematosus | D008178 | EFO_0003834 | L93.1 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use